A new study1 published in Nature compares the mechanisms used by SARS-CoV-1 and SARS-CoV-2 papain-like protease(PLpro)to promote innate immune evasion.Its findings identify SARS-CoV-2 PLpro as an attractive drug targe...A new study1 published in Nature compares the mechanisms used by SARS-CoV-1 and SARS-CoV-2 papain-like protease(PLpro)to promote innate immune evasion.Its findings identify SARS-CoV-2 PLpro as an attractive drug target for treating COVID-19.展开更多
文摘A new study1 published in Nature compares the mechanisms used by SARS-CoV-1 and SARS-CoV-2 papain-like protease(PLpro)to promote innate immune evasion.Its findings identify SARS-CoV-2 PLpro as an attractive drug target for treating COVID-19.
